Significant Ownership of ADAMS STREET PARTNERS LLC

Signature - Title
/s/ Sara Robinson Dasse - Sara Robinson Dasse, Executive Vice President
Location
Chicago, IL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by ADAMS STREET PARTNERS LLC.

Notify me when ADAMS STREET PARTNERS LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of ADAMS STREET PARTNERS LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CRVS Corvus Pharmaceuticals, Inc. Common Stock 3.9% $25,222,243 3,275,616 Adams Street Partners, LLC 23 Jan 2026
MLYS Mineralys Therapeutics, Inc. Common Stock 2.3% $15,320,183 1,129,807 Adams Street Partners, LLC 31 Dec 2024

Schedules 13D/G Reported by ADAMS STREET PARTNERS LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.